WeVote

Bill

Bill

HB 952

RELATING TO PARKINSON'S DISEASE RESEARCH.

2025 Regular Session Introduced by Terez Amato and 18 co-sponsors

Hawaii bill establishes Parkinson's disease research initiative; passed second reading, awaiting budget committee review for potential state funding allocation.

Reported from HHS (Stand. Com. Rep. No. 1262) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.
0
WeVote Research Nonpartisan
Bill Summary · HB 952

Legislative bill overview

HB 952 establishes a Parkinson's disease research initiative in Hawaii, likely including funding, research grants, or institutional support for studying the neurodegenerative condition. The bill has passed its second reading with amendments and is now under review by the Ways and Means Committee (WAM), which handles budget appropriations.

Why is this important

Parkinson's disease affects approximately 60,000 Americans, with numbers rising as the population ages. Hawaii's investment in disease-specific research could advance treatment options, improve outcomes for affected residents, and position the state as a research hub—potentially generating economic benefits through research jobs and attracting biomedical talent.

Potential points of contention

  • Budget impact: The bill's cost and funding source remain unclear from this legislative history; WAM will scrutinize fiscal implications during appropriations review
  • Research prioritization: Questions may arise about why Parkinson's receives dedicated funding versus other diseases, and whether this sets precedent for disease-specific research appropriations
  • Implementation scope: Unclear whether funding supports clinical trials, basic research, patient care infrastructure, or a combination—affecting real-world utility and measurable outcomes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.